Skip to content

Tarsus Pharmaceuticals, Inc. TARS Change in Inventories

Change in Inventories at other companies

AbbVie logo
AbbVieABBV
$184M+18.7%
Bausch + Lomb logo
Bausch + LombBLCO
$22M+83.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$173K-24.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$26.6M-117%
Warby Parker logo
Warby ParkerWRBY
$1.95M+152%
Glaukos logo
GlaukosGKOS
-$832K-150%

Other financials

Income statement

See full
Revenue$162.1M+107%
Gross profit$152.7M+109%
Operating income-$6.1M+76.7%
Net income-$7.0M+72.3%
EPS (diluted)-$0.16+75.0%

Balance sheet

See full
Cash & equivalents$104.2M-41.6%
Total debt$88.7M+22.5%
Total equity$349.0M+1.9%
Total assets$581.1M+16.1%

Cash flow

See full
Operating cash flow-$24.7M-19.4%
CapEx$5.8M+886%
Free cash flow-$30.5M-43.4%

Valuation

See full
Market cap$2.85B+41.1%
Enterprise value$2.83B+47.8%
P/S5.3×-3.3×

Profitability

See full
Gross margin42.7%
Operating margin-9.5%-4.2pp
Net margin-9%-4.0pp
FCF margin-28%-12.6pp

Returns & leverage

See full
Return on equity-14%-5.2pp
Debt / equity0.3×0.0×
Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s change in inventories?
Tarsus Pharmaceuticals, Inc. (TARS) reported change in inventories of $196K in Q1 2026.
How has Tarsus Pharmaceuticals, Inc.'s change in inventories changed year-over-year?
Tarsus Pharmaceuticals, Inc.'s change in inventories increased by 133.3% year-over-year, from $84K to $196K.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.